Runjian Co., Ltd. invested and established a number of new energy companies in Guizhou. The enterprise search APP shows that recently, Kaili Qida New Energy Co., Ltd., Kaili Xinsheng New Energy Co., Ltd. and Kaili Shunsheng New Energy Co., Ltd. were established, and their legal representatives are all Wen Feng, with a registered capital of 1 million yuan, and their business scope includes: energy-saving management services; Sales of construction machinery; Technical services for solar power generation; Research and development of wind farm related systems; Sales of wind turbines and parts; Power generation technical services, etc. Enterprise investigation shows that all three companies are indirectly wholly-owned by Runjian.The semiconductor sector bottomed out, and Purran shares rose by more than 17%. The semiconductor sector bottomed out, and Puran shares rose by more than 17%. Zhongke Lanxun, Zhaoyi Innovation, Hengxuan Technology, Shanghai Beiling and Jinghe Jicheng followed suit.Wang Tao of UBS: It is estimated that deficit ratio will approach 4% of its financial resources or increase its investment in social security medical care next year. Wang Tao, head of Asian economic research and chief China economist of UBS, said that China's fiscal deficit ratio is expected to approach 4% next year, and the scale of ultra-long-term special government bonds excluding capital injection into state-owned banks may be 2 trillion yuan, and the amount of new local government special bonds may be 4.5 trillion to 5 trillion yuan. In fact, the fiscal expansion next year is relatively mild compared with the fiscal stimulus in 2008-2009. Wang Tao believes that next year, the government will increase investment in social security and medical care, and establish a more perfect social security system while boosting residents' confidence in the short term.
Luo Zhiheng, Yuekai Securities: It is expected that the monetary policy will be further strengthened in 2025, or the RRR will be lowered or the interest rate will be reduced by 0.5 percentage points respectively. The Central Economic Work Conference will be held in Beijing from December 11 to 12. Luo Zhiheng, chief economist and dean of the research institute of Yuekai Securities, believes that overall, the tone of the meeting is more positive, and positive signals are released in terms of work objectives, policy tone and task deployment next year, which is conducive to strengthening and consolidating the momentum of sustained economic recovery next year. It is still a high probability that China's economy will achieve a growth rate of around 5% next year, as long as we implement greater fiscal and monetary policies, ensure that the policies work in the same direction, and promote a series of institutional reforms that restrict development. Luo Zhiheng predicts that in 2025, the monetary policy will be further strengthened, and the RRR and interest rate will be lowered by 0.5 percentage points respectively throughout the year; Rhythm or more advanced. In addition, the monetary policy toolbox will be further enriched and improved. On the one hand, it will adjust and optimize the policy tools such as refinancing of affordable housing, "convenient exchange of securities, funds and insurance companies" and stock repurchase and refinancing, which will be implemented and achieved practical results; On the other hand, we may appropriately narrow the width of the interest rate corridor and guide the money market interest rate to run smoothly around the policy interest rate center.CICC: It is expected that the central bank will further set up other new monetary instruments in the future. CICC said that on the basis of Politburo meeting of the Chinese Communist Party, the policy objectives and directions of the Central Economic Work Conference have been further stated. For next year's economic goals, after "maintaining stable economic growth", the meeting proposed to "maintain overall stability in employment and prices" and pointed out that "we should pay attention to target guidance and strive to achieve an optimal combination of stable growth, stable employment and reasonable price recovery". In terms of monetary policy, CICC believes that this meeting clearly pointed out that "timely RRR cuts and interest rate cuts". It is expected that in order to meet the government bond issuance, credit supply and seasonal liquidity demand, the RRR cut may be implemented before the Spring Festival, and the interest rate cut may also be gradually promoted with the Fed's interest rate cut. CICC also judged that in the past period, the central bank has established new monetary instruments such as treasury bonds trading tools, securities fund insurance company exchange facilities, and affordable housing refinancing, and its ability to play a role in the stock, bond, real estate and other markets has been strengthened, and other new instruments may be further established in the future. (SSE)Li Zaiming, leader of the largest opposition party in South Korea, issued a statement urging members of the ruling party to support the impeachment of Yin Xiyue. Li Zaiming, leader of the Common Democratic Party, the largest opposition party in South Korea, issued a statement in the National Assembly on the 13th, calling on members of the ruling party, members of the National Force, to vote on the impeachment case of President Yin Xiyue on the 14th and support the passage of the case.
CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.Dalian Shengya had a daily limit in the afternoon, and its share price hit a record high. Since November, its cumulative increase has exceeded 150%.Pinduoduo's concept oscillates higher, which is worth buying up by over 10%, and Pinduoduo's concept oscillates higher, which is worth buying up by over 10%. If Yuchen has a daily limit, Yuanlong Yatu, Xuan Ya International, rebate technology, online and offline will follow suit.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
Strategy guide 12-14